Please assess the completion status of the following clinical trial:

Trial Title: Comprehensive Evaluation of Ischemic Heart Disease Using MRI

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Under an Institutional Committee on Human Research board approved protocol 80 patients with a suspected myocardial ischemic disease recruited from the cardiac cath laboratory will be recruited in this prospective study. Volunteers will be recruited for the purpose of protocol development and will not be included in analysis. All subjects will be screened for glomerular filtration rate (GFR) within 24 hours before the exam. All patients must have a GFR \> 30 mL/min/1.73m2 to be part of the study.~All subjects will be selected following the Nephrogenic Systemic Fibrosis (NSF) guidelines. All dialysis patients or end-stage renal disease patients with a creatinine clearance of \< 30 mL/min will not be selected for the study to avoid NSF. Patients with GFR \< 60 ml/min but \>30 ml/min will receive a reduced dose of Gadolinium contrast (0.1 ml/kg).~Exclusion Criteria:~1. Age \<18 years;~2. Known contraindication to MR imaging (such as pacemaker placement, magnetic implants, etc);~3. Claustrophobia;~4. Inability to perform an adequate breath-hold for imaging,~5. Inability to provide informed consent;~6. all subjects will be will be screened for GFR within 24 hours before the exam and subjects presenting with GFR \< 30 ml/min will be excluded;~7. Pregnant and lactating women;~8. Patients with hypersensitivity to gadolinium contrast agents, metoprolol, adenosine, or nitroglycerin;~9. Contra indication for Adenosine~   1. 2nd- or 3rd-degree atrioventricular block (except in patients with a functioning artificial pacemaker)~  2. Sinus node disease (except in patients with a functioning artificial~      pacemaker)~  3. Unstable angina~  4. Acute myocardial infarction~  5. Known or suspected bronchoconstrictive or bronchospastic lung~      disease (e.g., asthma)~  6. Hypersensitivity to adenosine~  7. Caffeine within 12-24 hours~  8. Theophylline and Dipyridamole products within 24 hours.~10. Contra indication for Metoprolol~    1. sinus bradycardia~   2. heart block greater than first degree~   3. Cardiac Failure~   4. Bronchospastic Disease~11. Contra indication for Nitroglycerin~    1. Early myocardial infarction, severe anemia, increased intracranial pressure, and those with a known hypersensitivity to nitroglycerin.~b .Administration of Nitrostat (nitroglycerin tablets, USP) is contraindicated in patients who are using Viagra® since Viagra has been shown to potentiate the hypotensive effects of organic nitrates.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ischemic heart disease patients (Type: EXPERIMENTAL): Patients with suspected ischemic heart disease prospectively recruited for first pass myocardial perfusion MRI. All subject to receive Gadolinium infusion of 0.075 mmol/kg at rate of 4 ml/sec. Adenosine administered at a rate of 0.14 mg/kg/min for a duration of 4 minutes to induce stress.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete